Truist Securities Reiterates Buy Rating on Gilead Sciences (GILD) as Early Trodelvy + Pembro 'Encouraging'
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating and $91.00 price target on Gilead Sciences (NASDAQ: GILD) after, at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
